Related Experiment Video
Updated: Aug 11, 2026
Intravital Microscopy of the Inguinal Lymph Node
Published on: April 4, 2011
An inter-observer and intra-observer variability study on the diagnosis of lymph node biopsy specimens
Insights
Pathologist agreement on lymph node biopsies varied. While benign vs. malignant and Hodgkin
Area of Science:
- Pathology
- Hematopathology
- Diagnostic accuracy
Background:
- Accurate lymph node biopsy interpretation is crucial for patient treatment.
- Morphological assessment alone can be challenging without ancillary studies.
Purpose of the Study:
- To assess inter-pathologist agreement on lymph node biopsy interpretation.
- To evaluate diagnostic consistency in differentiating lymphoma subtypes and grades.
Main Methods:
- Seven pathologists reviewed 100 lymph node biopsy specimens twice.
- Morphological interpretation was performed without clinical history or immunohistochemistry.
- Pathologists recorded diagnoses and confidence levels.
Main Results:
- High agreement was observed for benign vs. malignant and non-Hodgkin lymphoma vs. Hodgkin's disease.
- Considerably lower agreement was found for T-cell vs. B-cell phenotype and high-grade vs. low-grade lymphomas.
- Lack of agreement on grade is significant due to treatment implications.
Conclusions:
- Morphological interpretation alone has limitations in lymph node biopsy diagnosis.
- Subtyping and grading of lymphomas show considerable inter-pathologist variability.
- Proliferation markers may offer more objective criteria for treatment selection.
Abstract:
One hundred lymph node biopsy specimens were examined on two separate occasions by seven pathologists differing in experience in lymphoreticular pathology. Neither history nor immunohistochemistry was provided and the study, therefore, focused on morphological interpretation alone. The participants evaluated each case using a constructed response form in which the confidence with which they entered each response was also entered. Agreement on various points, between pathologists, between the two rounds, and with the referring centre was assessed. Whilst there was a high level of agreement over a diagnosis of benign vs. malignant and non-Hodgkin lymphoma vs. Hodgkin's disease, there was considerably less agreement over both T vs. B cell phenotype and high vs. low grade. The lack of agreement over grade, an evaluation which is usually made independent of immunohistochemistry, is particularly important, because of the relevance to selection of treatment. Proliferation markers may be more appropriate determinants of treatment choice.
